Latest Institutional Purchases of Avidity Biosciences, Inc. (RNA)
This list provides information on the latest institutional transactions involving Avidity Biosciences, Inc. (RNA) stock that were buys. The list includes the name of the institution, the number of shares exchanged, the range of values for the transaction, and the number of shares held by the institution after the purchase has occurred.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
BUY
|
- |
40.6KNew |
$1.18M - $2.13M
|
40.6K
$1.34M
|
|
Jan 24, 2025
Q4 2024
|
Abrdn PLC
|
BUY
|
- |
20.1K+ 80.83% |
$584K - $1.05M
|
44.9K
$1.48M
|
|
Jan 29, 2025
Q4 2024
|
Legato Capital Management LLC
|
BUY
|
- |
10.3KNew |
$301K - $543K
|
10.3K
$340K
|
|
Jan 31, 2025
Q4 2024
|
Principal Financial Group Inc
Des Moines, IA |
BUY
|
- |
9.45KNew |
$275K - $496K
|
9.45K
$311K
|
|
Jan 30, 2025
Q4 2024
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
4.8K+ 3.22% |
$139K - $252K
|
154K
$5.06M
|
|
Jan 31, 2025
Q4 2024
|
State Of New Jersey Common Pension Fund D
|
BUY
|
- |
3.64K+ 8.1% |
$106K - $191K
|
48.5K
$1.6M
|
|
Jan 23, 2025
Q4 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
2.77K+ 12.31% |
$80.6K - $146K
|
25.3K
$833K
|
|
Jan 22, 2025
Q4 2024
|
Kbc Group Nv
|
BUY
|
- |
2.23K+ 99.02% |
$64.7K - $117K
|
4.47K
$147K
|
|
Jan 29, 2025
Q4 2024
|
Van Eck Associates Corp
|
BUY
|
- |
1.32KNew |
$38.2K - $69K
|
1.32K
$43.3K
|
|
Jan 31, 2025
Q4 2024
|
New York State Common Retirement Fund
|
BUY
|
- |
598+ 0.32% |
$17.4K - $31.4K
|
185K
$6.09M
|
|
Jan 15, 2025
Q4 2024
|
Aaron Wealth Advisors LLC
|
BUY
|
- |
504+ 6.63% |
$14.7K - $26.5K
|
8.1K
$267K
|
|
Jan 22, 2025
Q4 2024
|
R Squared LTD
Central, K3 |
BUY
|
- |
490New |
$14.2K - $25.7K
|
490
$16.1K
|
|
Jan 17, 2025
Q4 2024
|
Janney Montgomery Scott LLC
|
BUY
|
- |
240+ 2.84% |
$6.98K - $12.6K
|
8.7K
$286K
|
|
Jan 16, 2025
Q4 2024
|
Massmutual Trust CO Fsb
|
BUY
|
- |
54New |
$1.57K - $2.84K
|
54
$1.78K
|
|
Jan 30, 2025
Q4 2024
|
Principal Securities, Inc.
Des Moines, IA |
BUY
|
- |
9+ 25.0% |
$262 - $473
|
45
$1.48K
|
|
Jan 22, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
BUY
|
- |
8New |
$233 - $420
|
8
$263
|
|
Q3 2024 | |||||||
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
3.28M+ 55.24% |
$122M - $158M
|
9.23M
$304M
|
|
Nov 14, 2024
Q3 2024
|
Wellington Management Group LLP
Boston, MA |
BUY
|
- |
3.23M+ 84.93% |
$120M - $155M
|
7.03M
$232M
|
|
Nov 13, 2024
Q3 2024
|
Siren, L.L.C.
New York, NY |
BUY
|
- |
1.44MNew |
$53.6M - $69.4M
|
1.44M
$47.4M
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
1.39M+ 41.75% |
$51.6M - $66.7M
|
4.71M
$155M
|
|
Nov 14, 2024
Q3 2024
|
Janus Henderson Group PLC
London, X0 |
BUY
|
- |
1.24M+ 33.89% |
$46.1M - $59.7M
|
4.9M
$161M
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.15M+ 602.16% |
$42.9M - $55.4M
|
1.34M
$44.2M
|
|
Nov 14, 2024
Q3 2024
|
Man Group PLC
London, X0 |
BUY
|
- |
910KNew |
$33.9M - $43.8M
|
910K
$30M
|
|
Nov 14, 2024
Q3 2024
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
900K+ 16.67% |
$33.5M - $43.3M
|
6.3M
$207M
|
|
Nov 14, 2024
Q3 2024
|
Driehaus Capital Management LLC
Chicago, IL |
BUY
|
- |
872KNew |
$32.4M - $42M
|
872K
$28.7M
|
|
Nov 14, 2024
Q3 2024
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
625K+ 147.06% |
$23.3M - $30.1M
|
1.05M
$34.6M
|
|
Nov 12, 2024
Q3 2024
|
Bio Impact Capital LLC
Cambridge, MA |
BUY
|
- |
564K+ 451.18% |
$21M - $27.1M
|
689K
$22.7M
|
|
Nov 14, 2024
Q3 2024
|
Deep Track Capital, LP
Greenwich, CT |
BUY
|
- |
475KNew |
$17.7M - $22.9M
|
475K
$15.6M
|
|
Nov 14, 2024
Q3 2024
|
Polar Capital Holdings PLC
London, X0 |
BUY
|
- |
428K+ 38.42% |
$15.9M - $20.6M
|
1.54M
$50.8M
|
|
Nov 12, 2024
Q3 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
BUY
|
- |
407K+ 107.08% |
$15.1M - $19.6M
|
786K
$25.9M
|
|
Nov 14, 2024
Q3 2024
|
Avoro Capital Advisors LLC
New York, NY |
BUY
|
- |
370K+ 5.69% |
$13.8M - $17.8M
|
6.88M
$226M
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
370K+ 50.01% |
$13.8M - $17.8M
|
1.11M
$36.5M
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
- |
338K+ 47.89% |
$12.6M - $16.3M
|
1.04M
$34.4M
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
331K+ 60.78% |
$12.3M - $15.9M
|
875K
$28.8M
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
329K+ 14.56% |
$12.2M - $15.8M
|
2.59M
$85.1M
|
|
Nov 13, 2024
Q3 2024
|
Candriam S.C.A.
|
BUY
|
- |
323KNew |
$12M - $15.6M
|
323K
$10.6M
|
|
Nov 08, 2024
Q3 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
BUY
|
- |
212K+ 3836.6% |
$7.87M - $10.2M
|
217K
$7.15M
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
211K+ 27.77% |
$7.85M - $10.2M
|
971K
$32M
|
|
Nov 12, 2024
Q3 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
BUY
|
- |
197K+ 24.85% |
$7.33M - $9.49M
|
990K
$32.6M
|
|
Nov 15, 2024
Q3 2024
|
Barclays PLC
London, X0 |
BUY
|
- |
164K+ 178.56% |
$6.1M - $7.89M
|
256K
$8.42M
|
|
Nov 14, 2024
Q3 2024
|
Cutter Capital Management, LP
New York, NY |
BUY
|
- |
161KNew |
$5.99M - $7.75M
|
161K
$5.3M
|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
BUY
|
- |
161KNew |
$5.98M - $7.74M
|
161K
$5.3M
|
|
Nov 14, 2024
Q3 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
BUY
|
- |
125K+ 30.14% |
$4.65M - $6.01M
|
539K
$17.8M
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
BUY
|
CALL |
100KNew |
$3.72M - $4.81M
|
100K
$3.29M
|
|
Nov 12, 2024
Q3 2024
|
Seven Eight Capital, LP
|
BUY
|
- |
82.2KNew |
$3.06M - $3.96M
|
82.2K
$2.71M
|
|
Nov 13, 2024
Q3 2024
|
Rafferty Asset Management, LLC
New York, NY |
BUY
|
- |
78.8K+ 65.37% |
$2.93M - $3.79M
|
199K
$6.57M
|
|
Nov 13, 2024
Q3 2024
|
Atika Capital Management LLC
New York, NY |
BUY
|
- |
74KNew |
$2.75M - $3.56M
|
74K
$2.44M
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
73.5K+ 70.41% |
$2.73M - $3.54M
|
178K
$5.86M
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
70.4K+ 63.02% |
$2.62M - $3.39M
|
182K
$6M
|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
BUY
|
- |
67.8K+ 154.28% |
$2.52M - $3.26M
|
112K
$3.68M
|